Skip to main content
SpringerPlus

Table 1 Respiratory function tests of the patient with times in reference to her admission

From: Suspected acute exacerbation of idiopathic pulmonary fibrosis associated with interferon alpha therapy for hepatitis C: case report

 

9 months earlier

4 months earlier

FEV1 - L (% predicted)

2.26 (88)

2.13 (83)

FVC - L (% predicted)

3.60 (111)

3.38 (105)

FEV1/FVC (% predicted)

0.63 (79)

0.63 (80)

TLC – L (% predicted)

5.38 (106)

5.05 (100)

DLCO/VA - mL/min/mmHg/L (% predicted)

1.62 (35)

1.64 (35)

  1. FEV1, forced expiratory volume in one second; FVC, forced vital capacity; TLC, total lung capacity; DLCO, carbon monoxide diffusing capacity; VA, alveolar volume.
Back to article page